Anbio Biotechnology (NNNN) Revenue 2022–2025
Anbio Biotechnology (NNNN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$8.6MFY2025 · since FY2022: $23.5M → $8.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8.6M | +5.6% |
| FY2024 | $8.2M | +21.9% |
| FY2023 | $6.7M | -71.5% |
| FY2022 | $23.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice